ツムラの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/09/14 | 3,090 | 3,100 | 3,055 | 3,065 | -80 | -2.5% | 134,600 |
| 2022/09/13 | 3,140 | 3,155 | 3,120 | 3,145 | +15 | +0.5% | 69,800 |
| 2022/09/12 | 3,160 | 3,170 | 3,110 | 3,130 | -20 | -0.6% | 135,700 |
| 2022/09/09 | 3,135 | 3,165 | 3,135 | 3,150 | -5 | -0.2% | 204,200 |
| 2022/09/08 | 3,160 | 3,175 | 3,130 | 3,155 | +35 | +1.1% | 166,000 |
| 2022/09/07 | 3,155 | 3,155 | 3,080 | 3,120 | -60 | -1.9% | 179,400 |
| 2022/09/06 | 3,185 | 3,220 | 3,155 | 3,180 | -15 | -0.5% | 87,000 |
| 2022/09/05 | 3,175 | 3,245 | 3,165 | 3,195 | +30 | +0.9% | 181,800 |
| 2022/09/02 | 3,160 | 3,175 | 3,135 | 3,165 | +20 | +0.6% | 137,900 |
| 2022/09/01 | 3,165 | 3,180 | 3,135 | 3,145 | -50 | -1.6% | 114,900 |
| 2022/08/31 | 3,120 | 3,195 | 3,120 | 3,195 | +40 | +1.3% | 168,000 |
| 2022/08/30 | 3,195 | 3,195 | 3,130 | 3,155 | +10 | +0.3% | 67,400 |
| 2022/08/29 | 3,130 | 3,150 | 3,115 | 3,145 | -55 | -1.7% | 80,100 |
| 2022/08/26 | 3,180 | 3,215 | 3,175 | 3,200 | -15 | -0.5% | 107,800 |
| 2022/08/25 | 3,205 | 3,225 | 3,195 | 3,215 | -10 | -0.3% | 131,500 |
| 2022/08/24 | 3,225 | 3,235 | 3,210 | 3,225 | -25 | -0.8% | 76,100 |
| 2022/08/23 | 3,230 | 3,260 | 3,210 | 3,250 | -40 | -1.2% | 91,600 |
| 2022/08/22 | 3,210 | 3,295 | 3,210 | 3,290 | +75 | +2.3% | 80,400 |
| 2022/08/19 | 3,255 | 3,280 | 3,210 | 3,215 | -60 | -1.8% | 159,800 |
| 2022/08/18 | 3,270 | 3,290 | 3,250 | 3,275 | +15 | +0.5% | 125,400 |
| 2022/08/17 | 3,250 | 3,290 | 3,240 | 3,260 | +50 | +1.6% | 168,900 |
| 2022/08/16 | 3,170 | 3,220 | 3,155 | 3,210 | +10 | +0.3% | 100,200 |
| 2022/08/15 | 3,160 | 3,200 | 3,150 | 3,200 | +20 | +0.6% | 74,500 |
| 2022/08/12 | 3,115 | 3,200 | 3,100 | 3,180 | +75 | +2.4% | 157,100 |
| 2022/08/10 | 3,060 | 3,105 | 3,050 | 3,105 | +35 | +1.1% | 117,000 |
| 2022/08/09 | 3,105 | 3,115 | 3,060 | 3,070 | -30 | -1% | 90,700 |
| 2022/08/08 | 3,100 | 3,115 | 3,070 | 3,100 | -25 | -0.8% | 89,100 |
| 2022/08/05 | 3,055 | 3,125 | 3,055 | 3,125 | +5 | +0.2% | 94,000 |
| 2022/08/04 | 3,130 | 3,140 | 3,050 | 3,120 | +100 | +3.3% | 259,100 |
| 2022/08/03 | 3,100 | 3,100 | 3,015 | 3,020 | -50 | -1.6% | 104,600 |
| 2022/08/02 | 3,155 | 3,160 | 3,070 | 3,070 | -100 | -3.2% | 119,000 |
| 2022/08/01 | 3,120 | 3,175 | 3,110 | 3,170 | +55 | +1.8% | 75,300 |
| 2022/07/29 | 3,205 | 3,205 | 3,110 | 3,115 | -90 | -2.8% | 113,300 |
| 2022/07/28 | 3,190 | 3,220 | 3,180 | 3,205 | +15 | +0.5% | 90,000 |
| 2022/07/27 | 3,180 | 3,205 | 3,180 | 3,190 | -15 | -0.5% | 64,000 |
| 2022/07/26 | 3,250 | 3,250 | 3,205 | 3,205 | -30 | -0.9% | 56,000 |
| 2022/07/25 | 3,245 | 3,250 | 3,220 | 3,235 | -15 | -0.5% | 71,500 |
| 2022/07/22 | 3,230 | 3,275 | 3,220 | 3,250 | +20 | +0.6% | 89,100 |
| 2022/07/21 | 3,165 | 3,240 | 3,165 | 3,230 | +30 | +0.9% | 77,000 |
| 2022/07/20 | 3,175 | 3,200 | 3,140 | 3,200 | +55 | +1.7% | 90,400 |
| 2022/07/19 | 3,180 | 3,180 | 3,115 | 3,145 | -55 | -1.7% | 65,500 |
| 2022/07/15 | 3,210 | 3,220 | 3,170 | 3,200 | -5 | -0.2% | 58,900 |
| 2022/07/14 | 3,200 | 3,220 | 3,170 | 3,205 | +15 | +0.5% | 64,500 |
| 2022/07/13 | 3,220 | 3,225 | 3,180 | 3,190 | -10 | -0.3% | 88,100 |
| 2022/07/12 | 3,215 | 3,220 | 3,165 | 3,200 | -20 | -0.6% | 100,400 |
| 2022/07/11 | 3,205 | 3,225 | 3,190 | 3,220 | +60 | +1.9% | 122,800 |
| 2022/07/08 | 3,150 | 3,195 | 3,090 | 3,160 | +5 | +0.2% | 127,300 |
| 2022/07/07 | 3,165 | 3,170 | 3,135 | 3,155 | +50 | +1.6% | 118,400 |
| 2022/07/06 | 3,085 | 3,115 | 3,080 | 3,105 | ±0 | ±0% | 87,100 |
| 2022/07/05 | 3,115 | 3,120 | 3,085 | 3,105 | -15 | -0.5% | 98,300 |
701～
750
件表示中 / 3749件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ツムラ | 366,000円 | +3.8% | -19.9% | 3.72% | 11.89倍 | 0.91倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 住友ファーマ | 114,600円 | -11.0% | +206.6% | 0.00% | 11.38倍 | 2.69倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 久光薬 | 398,200円 | +5.8% | +1.2% | 3.01% | 12.89倍 | 1.03倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 日本新薬 | 319,900円 | +8.0% | -15.3% | 3.88% | 8.98倍 | 0.87倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 194,200円 | +5.9% | +684.6% | 2.83% | 12.89倍 | 1.29倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
チャート関連のコラム
